Immediate Impact
4 from Science/Nature 83 standout
Citing Papers
Neutrophil Membrane‐Camouflaged Polyprodrug Nanomedicine for Inflammation Suppression in Ischemic Stroke Therapy
2024 Standout
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies
2023 Standout
Works of EW Radue being referenced
Disease control and safety in relapsing remitting multiple sclerosis (RRMS) patients switching from natalizumab to fingolimod: a 32-week, rater- and patient-blind, randomized, parallel-group study (TOFINGO)
2013
Long-Term Efficacy and Safety of Fingolimod (FTY720) in Relapsing-Remitting Multiple Sclerosis (RRMS): Results from the Extension of the Phase III FREEDOMS Study (S41.004)
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| EW Radue | 324 | 157 | 18 | 159 | 14 | 658 | |
| Sherrill Purves | 466 | 74 | 20 | 107 | 13 | 831 | |
| Léorah Freeman | 437 | 198 | 30 | 65 | 36 | 761 | |
| Angela Pisani | 394 | 142 | 2 | 71 | 12 | 609 | |
| Eva Milano | 253 | 114 | 8 | 59 | 15 | 602 | |
| L Metz | 398 | 77 | 13 | 121 | 15 | 720 | |
| Ernst W. Radü | 239 | 66 | 7 | 104 | 18 | 713 | |
| O Lyon-Caen | 383 | 88 | 12 | 45 | 35 | 814 | |
| Rozie Arnaoutelis | 540 | 145 | 4 | 62 | 5 | 782 | |
| David Paling | 432 | 91 | 11 | 34 | 32 | 706 | |
| Seth Bouvier | 263 | 65 | 47 | 288 | 9 | 771 |
All Works
Loading papers...